Baseline low serum dehydroepiandrosterone sulfate can predict poor responsiveness to hormone therapy in patients with hormone‐naïve prostate cancer with skeletal metastases
Akihiro Yano; Makoto Kagawa; Hideki Takeshita; Yohei Okada; Makoto Morozumi; Satoru Kawakami
Author Information: Department of Urology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.